News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
22,694 Results
Type
Article (1032)
Company Profile (2)
Press Release (21660)
Section
Business (11379)
Career Advice (68)
Deals (1359)
Drug Delivery (1)
Drug Development (1765)
FDA (329)
Job Trends (586)
News (14163)
Policy (572)
Tag
Academia (21)
Allergies (5)
Alliances (660)
ALS (1)
Alzheimer's disease (24)
Antibody-drug conjugate (ADC) (7)
Approvals (349)
Artificial intelligence (6)
Autoimmune disease (10)
Bankruptcy (4)
Best Places to Work (540)
Biosimilars (4)
Biotechnology (1)
Bladder cancer (7)
Brain cancer (1)
Breast cancer (16)
Cancer (160)
Cardiovascular disease (14)
Career advice (51)
Career pathing (3)
CAR-T (3)
Cell therapy (11)
Cervical cancer (3)
Clinical research (1713)
Collaboration (13)
Compensation (15)
Complete response letters (1)
COVID-19 (29)
CRISPR (4)
C-suite (2)
Cystic fibrosis (3)
Data (238)
Depression (2)
Dermatology (2)
Diabetes (14)
Diagnostics (205)
Digital health (2)
Drug discovery (5)
Drug pricing (1)
Duchenne muscular dystrophy (3)
Earnings (11314)
Events (2201)
Executive appointments (1)
FDA (502)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Funding (17)
Gene editing (7)
Gene therapy (11)
GLP-1 (20)
Government (49)
Guidances (123)
Healthcare (516)
HIV (1)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (10)
Indications (7)
Infectious disease (37)
Inflammatory bowel disease (3)
Influenza (4)
Intellectual property (5)
Interviews (14)
IPO (1026)
IRA (1)
Job creations (86)
Job search strategy (42)
JPM (1)
Kidney cancer (2)
Labor market (5)
Layoffs (10)
Legal (108)
Lung cancer (37)
Lymphoma (14)
Manufacturing (14)
MASH (7)
Medical device (542)
Medtech (546)
Mergers & acquisitions (338)
Metabolic disorders (33)
mRNA (1)
Multiple sclerosis (1)
Neurodegenerative disease (6)
Neuropsychiatric disorders (4)
Neuroscience (57)
Neurotech (1)
NextGen: Class of 2026 (130)
Non-profit (42)
Obesity (12)
Ovarian cancer (2)
Pain (2)
Pancreatic cancer (3)
Parkinson's disease (2)
Partnered (1)
Patents (3)
Patient recruitment (6)
Peanut (1)
People (612)
Phase 1 (379)
Phase 2 (610)
Phase 3 (823)
Pipeline (669)
Policy (1)
Postmarket research (61)
Preclinical (134)
Prostate cancer (5)
Radiopharmaceuticals (10)
Rare diseases (17)
Real estate (93)
Regulatory (489)
Reports (9)
Research institute (23)
Resumes & cover letters (11)
Rett syndrome (1)
RSV (4)
Schizophrenia (13)
Series A (1)
Series B (3)
Sickle cell disease (3)
Special edition (4)
Spinal muscular atrophy (3)
Sponsored (1)
Startups (53)
Supply chain (2)
Vaccines (12)
Venture capital (1)
Weight loss (7)
Women's health (4)
Worklife (1)
Date
Last 7 days (26)
Last 30 days (121)
Last 365 days (1263)
2026 (337)
2025 (1233)
2024 (1439)
2023 (1680)
2022 (1806)
2021 (1788)
2020 (1535)
2019 (1012)
2018 (914)
2017 (621)
2016 (339)
2015 (6567)
2014 (446)
2013 (239)
2012 (269)
2011 (344)
2010 (302)
Location
Africa (35)
Alabama (1)
Arizona (8)
Asia (1413)
Australia (163)
California (470)
Canada (143)
China (32)
Colorado (23)
Connecticut (44)
Delaware (16)
Europe (3049)
Florida (75)
Georgia (15)
Illinois (28)
India (1)
Indiana (43)
Japan (12)
Kansas (1)
Kentucky (3)
Louisiana (4)
Maine (5)
Maryland (56)
Massachusetts (323)
Michigan (17)
Minnesota (29)
Missouri (7)
Montana (1)
Nevada (5)
New Hampshire (3)
New Jersey (196)
New York (125)
North Carolina (78)
Northern California (260)
Ohio (13)
Oklahoma (1)
Pennsylvania (107)
South America (51)
Southern California (177)
Tennessee (5)
Texas (71)
United States (1807)
Utah (14)
Virginia (5)
Washington State (40)
Wisconsin (7)
22,694 Results for "153".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
Sanofi Bets Up to $1.53B in Hong Kong Immuno Pact, Adding to String of Deals
Sanofi will gain global exclusive rights over rovadicitinib, an oral JAK/ROCK blocker that has anti-inflammatory and anti-fibrotic effects.
March 4, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Arthrosi Secures $153 Million in Series E Financing to Complete Pivotal Development of Pozdeutinurad for the Treatment of Gout and Tophaceous Gout
October 9, 2025
·
3 min read
Cancer
Big Pharma-Backed mRNA Startup Bags $153M Series B Amid Policy Headwinds
Strand Therapeutics’ lead asset is STX-001, an intra-tumor self-replicating mRNA therapy that carries a payload expressing the immunomodulatory protein IL-12.
August 7, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Strand Therapeutics Raises $153 Million Series B Financing to Further Advance Programmable mRNA Therapeutic Pipeline
August 7, 2025
·
5 min read
Press Releases
Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering
March 6, 2025
·
2 min read
Clinical Trials Market Size to Increase USD 153.59 Billion by 2033
According to Nova One Advisor, the global clinical trials market size was estimated at USD 81.90 billion in 2023 and it is projected to increase USD 153.59 billion by 2033 with a CAGR of 6.49% from 2024 to 2033.
April 9, 2024
·
17 min read
China Jo-Jo Drugstores Announces $1.53 Million Registered Direct Offering
China Jo-Jo Drugstores, Inc. announced that it has entered into definitive agreements with a number of investors providing for the issuance of 0.9 million ordinary shares, at a purchase price of $1.70 per share, in a registered direct offering for aggregate gross proceeds of approximately $1.53 million.
April 29, 2024
·
3 min read
Transgene Receives $15.3 Million from the Sale of Securities Held for Sale
Regulatory News: Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announced that it has received $15.3 million as a result of the full disposal of its minority stake in a Chinese biopharmaceutical company.
July 17, 2023
·
3 min read
EXCELLENT CLINICAL DATA FOR SUBB2M/CA15-3 BREAST CANCER TEST
INOVIQ Limited (ASX:IIQ) (INOVIQ or the Company), a developer of next-generation exosome solutions and precision diagnostics, is pleased to announce excellent results from an independent clinical validation study of its SubB2M/CA15-3 test for breast cancer detection.
June 27, 2023
·
9 min read
Cancer Immunotherapy Market Size Worth USD 153.03 Billion by 2027
The global Cancer Immunotherapy Market is expected to reach USD 153.03 Billion by 2027, according to a new report by Emergen Research.
August 17, 2022
·
5 min read
1 of 2,270
Next
